
Bio-Techne (TECH) Earnings Dates & Reports
Bio-Techne (TECH) Most Recent Earnings
Report DateNov 5, 2025
Period EndingQ1 2026
Est. EPS$0.40
Actual EPS$0.42
EarningsBeat
Bio-Techne (TECH) Earnings
View the latest Bio-Techne (TECH) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Bio-Techne (TECH)
Order type
Buy in
Order amount
Est. shares
0 shares
Bio-Techne (TECH) Earnings per Share (EPS) History
Signup for full accessBrowse free
Bio-Techne (TECH) Latest Earnings
The value each TECH share was expected to gain vs. the value each share gained.
Bio-Techne (TECH) reported its most recent earnings on Nov 5, 2025 for Q1 2026, posting earnings per share (EPS) of $0.42. This exceeded analysts' expectations of $0.40 by 5.00%, marking a Beat.
For comparison, Bio-Techne reported EPS of $0.42 in the same quarter last year.
The company is expected to announce its next earnings report on 02/04/2026, with analysts projecting an EPS of $0.40.
Bio-Techne (TECH) Earnings History
Bio-Techne (TECH) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Bio-Techne’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| Nov 5, 2025 | — | — | — |
| Aug 6, 2025 | — | — | — |
| May 7, 2025 | — | — | — |
| Feb 5, 2025 | — | — | — |
Bio-Techne (TECH) Earnings FAQs
Bio-Techne (TECH) last reported earnings on Nov 5, 2025 for Q1 2026, posting an EPS of $0.42, which Beat the estimate of $0.40 by 5.00%.
For Q1 2026, Bio-Techne (TECH) reported an EPS of $0.42, exceeding analysts' estimate of $0.40 by 5.00%.
For Q1 2026, Bio-Techne (TECH) Beat expectations with an actual EPS of $0.42 vs. an estimated EPS of $0.40.
Following the last earnings report on Nov 5, 2025, Bio-Techne (TECH)'s stock price moved — from — to —.
The next Bio-Techne (TECH) earnings call is scheduled for Feb. 4, 2026, where executives will discuss financial results and outlook.